Clinical Trials Directory

Trials / Unknown

UnknownNCT04682886

Radiomics Analysis of Focal Liver Lesions Based on Contrast-Enhanced Ultrasound Imaging

Research on Key Techniques for Intelligent Diagnosis and Ablation Decision-making of Liver Cancer and Evolution by Contrast-enhanced Ultrasound

Status
Unknown
Phase
Study type
Observational
Enrollment
5,000 (estimated)
Sponsor
Ping Liang · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Contrast-enhanced ultrasound (CEUS) substantially improves the potential of ultrasound (US) for the identification and characterization of focal liver lesions (FLLs). Compared to contrasted-enhanced MRI and CT, it has some unique advantages, such as the absence of ionizing radiation, and easy operability and repeatability. However, the efficacy of CEUS in diagnosing liver lesions is challenged by several factors including being highly dependent on doctor's experience, low signal-to-noise ratio, and low interobserver agreement. Therefore, it is a beneficial attempt to construct an intelligent CEUS diagnosis system using digital information technology. This study aims to collect standard data of CEUS cines recordings and develop deep learning model for accurate segmentation, detection and classification of liver lesions.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTdiagnosisthere is no intervention diagnosis or treatment for patients

Timeline

Start date
2017-01-01
Primary completion
2024-12-31
Completion
2025-12-31
First posted
2020-12-24
Last updated
2020-12-24

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04682886. Inclusion in this directory is not an endorsement.